{"id":5447,"date":"2022-05-04T14:21:29","date_gmt":"2022-05-04T12:21:29","guid":{"rendered":"http:\/\/stiftkgj.webforslag.com\/senter\/k-g-jebsen-senter-for-immunterapi-mot-kreft\/"},"modified":"2022-08-23T20:33:40","modified_gmt":"2022-08-23T18:33:40","slug":"k-g-jebsen-centre-for-cancer-immunotherapy","status":"publish","type":"senter","link":"https:\/\/stiftkgj.no\/en\/senter\/k-g-jebsen-centre-for-cancer-immunotherapy\/","title":{"rendered":"K.G. Jebsen Centre for Cancer Immunotherapy"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row css=&#8221;.vc_custom_1651580050061{margin-right: 0px !important;margin-left: 0px !important;background-image: url(https:\/\/stiftkgj.no\/wp-content\/uploads\/2022\/04\/Topp-bilde-2.jpg?id=427) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}&#8221;][vc_column]<div class=\"spacer-5830a5ea62c1f2880975a2ceab4a96be2\" style=\"\"><\/div><style>@media (min-width: 320px) { .spacer-5830a5ea62c1f2880975a2ceab4a96be2{ height: 200px;}}@media (min-width: 767px) { .spacer-5830a5ea62c1f2880975a2ceab4a96be2{ height: 200px;}}@media (min-width: 979px) { .spacer-5830a5ea62c1f2880975a2ceab4a96be2{ height: 400px;}}@media (min-width: 1200px) { .spacer-5830a5ea62c1f2880975a2ceab4a96be2{ height: 400px;}}<\/style>[\/vc_column][\/vc_row][vc_row el_class=&#8221;article-white&#8221; css=&#8221;.vc_custom_1649536549777{margin-right: 0px !important;margin-left: 0px !important;}&#8221;][vc_column][vc_row_inner][vc_column_inner]<div class=\"spacer-f96c97828f0d47b1724343c705ecae9d423\" style=\"\"><\/div><style>@media (min-width: 320px) { .spacer-f96c97828f0d47b1724343c705ecae9d423{ height: 10px;}}@media (min-width: 767px) { .spacer-f96c97828f0d47b1724343c705ecae9d423{ height: 10px;}}@media (min-width: 979px) { .spacer-f96c97828f0d47b1724343c705ecae9d423{ height: 10px;}}@media (min-width: 1200px) { .spacer-f96c97828f0d47b1724343c705ecae9d423{ height: 10px;}}<\/style><div class=\"header left  \"><h1 class=\"font-size-sm\" title=\"K.G. Jebsen Centre for Cancer Immunotherapy \" style=\"color:#0054a2\">K.G. Jebsen Centre for Cancer Immunotherapy <\/h1><\/div>[\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=&#8221;3\/4&#8243;][vc_video link=&#8221;https:\/\/player.vimeo.com\/video\/312944721?dnt=1&amp;app_id=122963&#8243;][vc_column_text]When the immune system is unable to fight cancer, the main problem is that the immune system does not perceive the cancer cells as alien. The KG Jebsen Centre for Cancer Immunotherapy plans to utilise new strategies to do something about this.<\/p>\n<div class=\"wpb_text_column wpb_content_element \">\n<div class=\"wpb_wrapper\">\n<p class=\"p1\"><span class=\"s1\">Our immune system is unsurpassed as regards combating infections. The immune cells recognise microbes and infected cells as alien and kill them efficiently without damaging normal cells. Cancer is more problematic because, in many cases, the immune system will ignore the cancer cells or even actively tolerate them. This centre will use new technology to manipulate the immune system to kill cancer cells as efficiently as virus-infected cells.<\/span><\/p>\n<\/div>\n<\/div>\n<div class=\"wpb_text_column wpb_content_element \">\n<div class=\"wpb_wrapper\">\n<p>It has been known for many years that the immune system rejects organs that are transplanted from other people. The research carried out by members of this centre indicates that such rejection reactions can be use in cancer treatment. They have succeeded in selecting immune cells from healthy individuals that reject cancer cells from another person. This opens for the possibility of transferring such selected immune cells to the patient\u2019s blood. There, they are expected to act as guided missiles that bombard the tumour, but spare healthy cells. An exciting alternative is the copy and paste principle, where genes from immune cells are copied in one individual and \u2018pasted\u2019 into the patient\u2019s own ones.<\/p>\n<\/div>\n<\/div>\n<div class=\"wpb_text_column wpb_content_element \">\n<div class=\"wpb_wrapper\">\n<p>In recent years, it has become clear that the immune system has brakes that prevent it from attacking cancer. A new treatment has been introduced, for example for malignant melanoma, which consists of blocking the brakes. Researchers at this centre are working to find new points to attack in the brakes. they are now in the process of testing medicines that may be more effective than those currently available.<\/p>\n<\/div>\n<\/div>\n<div class=\"wpb_text_column wpb_content_element \">\n<div class=\"wpb_wrapper\">\n<p>One of the researchers at the centre is an oncologist and specialist in the treatment of lymphatic cancer. He has led a study in which one of the patient\u2019s tumours in treated in such a way that the immune system perceives the condition as an infection. After that, cells are injected that are specialised in stimulating immune responses. This has led to full remission of the disease in several patients.<\/p>\n<\/div>\n<\/div>\n<div class=\"wpb_text_column wpb_content_element \">\n<div class=\"wpb_wrapper\">\n<p>Funding from the Foundation has enabled six research groups at the University of Oslo, Oslo University Hospital and the Netherlands Cancer Institute to unite their expertise and focus their work on a common goal. The head of the centre, Johanna Olweus, says that this presents completely new possibilities for achieving the ambition of exploiting the power and precision of the immune system in the fight against cancer.<\/p>\n<\/div>\n<\/div>\n<p>[\/vc_column_text]<div class=\"header left  \"><span class=\"font-size-xxs\" title=\"Group leaders\" >Group leaders<\/span><\/div><div class=\"header left  \"><span class=\"font-size-xss\" title=\"Johanna Olweus (senterleder)\" style=\"color:#0054a2\">Johanna Olweus (senterleder)<\/span><div class=\"subheader\"><p>Professor OUS, Radiumhospitalet and UiO.<\/p><\/div><\/div><div class=\"header left  \"><span class=\"font-size-xss\" title=\"Arne Kolstad\" style=\"color:#0054a2\">Arne Kolstad<\/span><div class=\"subheader\"><p>Consultant\u00a0dr. med. OUS-Radiumhospitalet.<\/p><\/div><\/div><div class=\"header left  \"><span class=\"font-size-xss\" title=\"Professor, UiO and OUH\" style=\"color:#0054a2\">Professor, UiO and OUH<\/span><div class=\"subheader\"><p>Professor ved Senter for molekyl\u00e6rmedisin i Norge, Nordisk EMBL Partnership og Bioteknologisenteret, Universitetet i Oslo og Avdeling for infeksjonsmedisin, Oslo universitetssykehus.<\/p><\/div><\/div><div class=\"header left  \"><span class=\"font-size-xss\" title=\"Fridtjof Lund-Johansen\" style=\"color:#0054a2\">Fridtjof Lund-Johansen<\/span><div class=\"subheader\"><p>Researcher,\u00a0\u00a0OUH and Rikshospitalet.<\/p><\/div><\/div><div class=\"header left  \"><span class=\"font-size-xss\" title=\"Ton Schumacher\" style=\"color:#0054a2\">Ton Schumacher<\/span><div class=\"subheader\"><p>Professor, The Netherlands Cancer Research Institute, Amsterdam, Nederland.<\/p><\/div><\/div><div class=\"header left  \"><h2 class=\"font-size-sm\" title=\"Mediaomtale\" >Mediaomtale<\/h2><\/div><div class=\"external-links-container light-blue\"><ul class=\"external-links\"><li class=\"inner-item\"><i class=\"fa fa-external-link\"><\/i><a href=\"https:\/\/www.nrk.no\/norge\/drepeceller-kan-ta-knekken-pa-kreft-1.13891554\" target=\"_blank\" rel=\"noopener\">NRK.no<\/a><span class=\"description\">Dreperceller kan ta knekken p\u00e5 kreft<\/span><span class=\"date\">31.1.2018<\/span><\/li><li class=\"inner-item\"><i class=\"fa fa-external-link\"><\/i><a href=\"https:\/\/www.dagensmedisin.no\/artikler\/2017\/04\/12\/utvikler-neste-generasjons-immunterapi\/\" target=\"_blank\" rel=\"noopener\">Dagens Medisin<\/a><span class=\"description\">Utvikler neste generasjons immunterapi<\/span><span class=\"date\">12.4.2017<\/span><\/li><li class=\"inner-item\"><i class=\"fa fa-external-link\"><\/i><a href=\"https:\/\/www.sciencedaily.com\/releases\/2016\/05\/160519144556.htm\" target=\"_blank\" rel=\"noopener\">Science Daily<\/a><span class=\"description\">Fighting cancer with the help of someone else\u2019s immune cells<\/span><span class=\"date\">19.5.2016<\/span><\/li><li class=\"inner-item\"><i class=\"fa fa-external-link\"><\/i><a href=\"https:\/\/hsorhf.prod.fpl.nhn.no\/aktuelt_\/nyheter_\/Sider\/--Gi-rom-for-de-gode-ideene.aspx\" target=\"_blank\" rel=\"noopener\">Oslo Universitetssykehus<\/a><span class=\"description\">Gi rom for de gode ideene<\/span><span class=\"date\">29.9.2014<\/span><\/li><li class=\"inner-item\"><i class=\"fa fa-external-link\"><\/i><a href=\"https:\/\/www.nrk.no\/viten\/norsk-gjennombrot-i-immunterapi-1.11422853\" target=\"_blank\" rel=\"noopener\">NRK<\/a><span class=\"description\">Norske forskarar med gjennombrot i m\u00e5lstyrt kreftbehandling<\/span><span class=\"date\">17.12.2013<\/span><\/li><\/ul><\/div>[\/vc_column_inner][vc_column_inner width=&#8221;1\/4&#8243;]<div class=\"infobox light-brown\"><h3>The centre in brief<\/h3><p>Leader: Johanna Olweus<br \/>\nStart up: 2013<br \/>\nHost institution: University of Oslo<br \/>\nFunding: 16 MNOK<br \/>\nHome page:\u00a0<a href=\"https:\/\/www.med.uio.no\/klinmed\/forskning\/sentre\/kgj-kreft-immunterapi\/om\/\" target=\"_blank\" rel=\"noopener noreferrer\">K.G. Jebsen-senter for immunterapi mot kreft<\/a><\/p><\/div><div class=\"infobox light-brown\"><h3>Contact information<\/h3><p><strong>Visiting address:<br \/>\n<\/strong>Seksjon for immunologi, Institutt for kreftforskning<br \/>\nOslo Universitetssykehus Radiumhospitalet<br \/>\nUllernchauss\u00e8en 70<br \/>\nForskningsbygget. 2. og 3. etg.<\/p>\n<p><strong>Postal address:<\/strong><br \/>\nOslo Universitetessykehus Radiumhospitalet<br \/>\nUllernchaus\u00e9en 70<br \/>\n0310 Oslo<\/p><\/div>[\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column]<div class=\"spacer-19ba46bd32479517faefa95d8bc53e873425752342356\" style=\"\"><\/div><style>@media (min-width: 320px) { .spacer-19ba46bd32479517faefa95d8bc53e873425752342356{ height: 30px;}}@media (min-width: 767px) { .spacer-19ba46bd32479517faefa95d8bc53e873425752342356{ height: 30px;}}@media (min-width: 979px) { .spacer-19ba46bd32479517faefa95d8bc53e873425752342356{ height: 60px;}}@media (min-width: 1200px) { .spacer-19ba46bd32479517faefa95d8bc53e873425752342356{ height: 60px;}}<\/style>[\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>When the immune system is unable to fight cancer, the main problem is that the immune system does not perceive the cancer cells as alien. The KG Jebsen Centre for Cancer Immunotherapy plans to utilise new strategies to do something about this. [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary vidiflex-read-more-link\" href=\"https:\/\/stiftkgj.no\/en\/senter\/k-g-jebsen-centre-for-cancer-immunotherapy\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"featured_media":497,"template":"","categories":[39],"class_list":["post-5447","senter","type-senter","status-publish","has-post-thumbnail","hentry","category-medical-research-old"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/stiftkgj.no\/en\/wp-json\/wp\/v2\/senter\/5447","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stiftkgj.no\/en\/wp-json\/wp\/v2\/senter"}],"about":[{"href":"https:\/\/stiftkgj.no\/en\/wp-json\/wp\/v2\/types\/senter"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stiftkgj.no\/en\/wp-json\/wp\/v2\/media\/497"}],"wp:attachment":[{"href":"https:\/\/stiftkgj.no\/en\/wp-json\/wp\/v2\/media?parent=5447"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stiftkgj.no\/en\/wp-json\/wp\/v2\/categories?post=5447"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}